GLAUrious long-term follow-up study of glaucoma laser treatment

Long-term observational follow-up of participants treated in the GLAUrious trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN96782911

Enrollment

192

Registered

2023-07-23

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Eye Diseases

Interventions

Cross sectional, observational study examining participants enrolled to the GLAUrious study having received either SLT or DSLT treatment as part of the randomized controlled trial. Qualified particip

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants enrolled to the GLAUrious study and treated with either the SLT or DSLT between November 2018 and May 2021

Exclusion criteria

Exclusion criteria: Participants who were not enrolled to the GLAUrious study and treated with either the SLT or DSLT between November 2018 and May 2021

Design outcomes

Primary

Measure	Time frame
Safety parameters (slit lamp exam). This observational study includes only one single visit.	—

Secondary

Measure	Time frame
Additional safety parameters (IOP, visual field, and fundus exam). This observational study includes only one single visit.	—

Countries

England, Georgia, Israel, Italy, Northern Ireland, United Kingdom

Contacts

Public ContactClinical Operations Manager

glauriousltfu@belkin-vision.com+972-8-8571619

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026